Health Sciences Acquisitions Corp (IMVTU)
followers
·
Follow
Sector:
FINANCE
Industry:
GENERAL FINANCE
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Peter Salzmann
Employees:
120
320 WEST 37TH STREET, NEW YORK, NY, 10018
917-580-3099
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
Are you looking for this stock instead?
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. IMVT-1401 is in Phase IIa clinical trials for the. treatment of myasthenia gravis and thyroid eye disease. The company is headquartered in New York, New York.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|